| Name | ADAMTS9 antisense RNA 2 |
| Description | Implicated in diabetic retinopathy. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Long non‐coding RNA ADAMTS9‐AS2 has emerged as a multifunctional regulator in human disease, most notably in cancer. In several independent studies, ADAMTS9‐AS2 is reported to be downregulated in tumor tissues compared with normal counterparts, and its reduced expression is frequently associated with enhanced cell proliferation, migration, invasion, therapy resistance, and poorer clinical outcomes in malignancies such as gastric cancer, glioma, lung cancer, ovarian cancer, colorectal cancer, bladder cancer, prostate cancer, liver cancer, and head and neck cancers."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "11"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Mechanistically, ADAMTS9‐AS2 primarily functions as a competing endogenous RNA (ceRNA) that “sponges” oncogenic microRNAs—such as miR‐223‑3p, miR‑182‑5p, miR‑27a‑3p, miR‑32, miR‑130a‑5p, and miR‑600—to relieve their inhibitory effects on key tumor‐suppressive targets. These targets include regulators of cell death and survival (e.g. NLRP3, TGFBR3, FOXF2, PTEN, FOXO1, PHLPP2, and EZH2), as well as genes controlling epithelial–mesenchymal transition and signaling pathways such as PI3K/AKT/mTOR."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}, {"type": "fg_fs", "start_ref": "3", "end_ref": "7"}, {"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": " These ceRNA‐mediated interactions underpin its tumor‐suppressive activities by inhibiting cell growth, metastasis, chemoresistance, and by modulating cell death pathways.\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In addition to its role in cancer, ADAMTS9‐AS2 has been implicated in other pathological settings. For instance, in ischemic stroke, reduced ADAMTS9‐AS2 levels correlate with larger infarct sizes, and its overexpression enhances angiogenesis via regulation of the miR‑185‑5p/IGFBP‑2 axis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": " Furthermore, in liver cancer, ADAMTS9‐AS2 regulates expression of its sense gene ADAMTS9 and suppresses tumor cell proliferation, migration, and invasion through modulation of PI3K/AKT/mTOR signaling."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Finally, the diagnostic and prognostic potential of ADAMTS9‐AS2 has been underscored in several studies. Its altered expression in body fluids and tumor tissues has been linked to tumor aggressiveness and patient survival in cancers such as non–small cell lung cancer, colorectal cancer, bladder urothelial carcinoma, and others."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "16", "end_ref": "20"}]}, {"type": "t", "text": " Collectively, these findings support the notion that ADAMTS9‐AS2 acts as a critical tumor suppressor and holds promise as a novel biomarker and therapeutic target across a spectrum of human cancers and other diseases.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Niansheng Ren, Tao Jiang, Chengbo Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.103314"}], "href": "https://doi.org/10.18632/aging.103314"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32516127"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32516127"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Jie Yao, Baosheng Zhou, Jian Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-014-1949-2"}], "href": "https://doi.org/10.1007/s13277-014-1949-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24833086"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24833086"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Chao Liu, Zuozhang Yang, Zhiyong Deng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "IUBMB Life (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/iub.1752"}], "href": "https://doi.org/10.1002/iub.1752"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29707897"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29707897"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Aihong Wang, Canhui Jin, Hongyu Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biol Macromol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ijbiomac.2018.09.179"}], "href": "https://doi.org/10.1016/j.ijbiomac.2018.09.179"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30268751"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30268751"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Y-F Shi, H Lu, H-B Wang "}, {"type": "b", "children": [{"type": "t", "text": "Downregulated lncRNA ADAMTS9-AS2 in breast cancer enhances tamoxifen resistance by activating microRNA-130a-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201902_17115"}], "href": "https://doi.org/10.26355/eurrev_201902_17115"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30840279"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30840279"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Er-Lin Song, Li Xing, Liang Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.102154"}], "href": "https://doi.org/10.18632/aging.102154"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31400752"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31400752"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Hongda Pan, Jingxin Pan, Shibo Song, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and development of long non-coding RNA-associated regulatory network in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.14395"}], "href": "https://doi.org/10.1111/jcmm.14395"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31144439"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31144439"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Qing Guo, Pinghua Ni, Yi Dai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long-Chain Noncoding RNA ADAMTS9-AS2 Regulates Proliferation, Migration, and Apoptosis in Bladder Cancer Cells Through Regulating miR-182-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Interferon Cytokine Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/jir.2020.0137"}], "href": "https://doi.org/10.1089/jir.2020.0137"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33621133"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33621133"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Lei He, Yin Xiao, Limin Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ADAMTS9-AS2: a potential diagnostic and prognostic hallmark in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J BUON (2021)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34565027"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34565027"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Xiaoyun Bu, Ang Qin, Zhi Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Overexpression of the long non-coding RNA ADAMTS9-AS2 suppresses colorectal cancer proliferation and metastasis]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhong Nan Da Xue Xue Bao Yi Xue Ban (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.11817/j.issn.1672-7347.2019.190142"}], "href": "https://doi.org/10.11817/j.issn.1672-7347.2019.190142"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31413211"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31413211"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Shanghui Zhou, Yun Zhu, Zhenming Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosome-derived long non-coding RNA ADAMTS9-AS2 suppresses progression of oral submucous fibrosis via AKT signalling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.16219"}], "href": "https://doi.org/10.1111/jcmm.16219"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33345447"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33345447"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Chengzu Wang, Guoping Yuan, Junjie Chen "}, {"type": "b", "children": [{"type": "t", "text": "Identification of lncRNAs Associated with Prognosis of Rectal Cancer by Comprehensive Bioinformatics Analysis Based on TCGA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Lab (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7754/Clin.Lab.2019.190133"}], "href": "https://doi.org/10.7754/Clin.Lab.2019.190133"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31710439"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31710439"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Yingru Li, Quan Wan, Weiwei Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA ADAMTS9-AS2 promotes tongue squamous cell carcinoma proliferation, migration and EMT via the miR-600/EZH2 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2019.108719"}], "href": "https://doi.org/10.1016/j.biopha.2019.108719"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30970517"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30970517"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Nianping Feng, Zhengfei Wang, Yun Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ADAMTS9-AS2 Promotes Angiogenesis of Brain Microvascular Endothelial Cells Through Regulating miR-185-5p/IGFBP-2 Axis in Ischemic Stroke."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Neurobiol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12035-021-02641-1"}], "href": "https://doi.org/10.1007/s12035-021-02641-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35098480"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35098480"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Hanjun Li, Hu Huang, Sha Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA ADAMTS9-AS2 inhibits liver cancer cell proliferation, migration and invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Ther Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/etm.2021.9991"}], "href": "https://doi.org/10.3892/etm.2021.9991"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33850531"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33850531"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Anetta Sulewska, Jacek Niklinski, Radoslaw Charkiewicz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A Signature of 14 Long Non-Coding RNAs (lncRNAs) as a Step towards Precision Diagnosis for NSCLC."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancers (Basel) (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/cancers14020439"}], "href": "https://doi.org/10.3390/cancers14020439"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35053601"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35053601"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Rehab S Abdul-Maksoud, Nearmeen M Rashad, Walid S H Elsayed, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The diagnostic significance of circulating lncRNA ADAMTS9-AS2 tumor biomarker in non-small cell lung cancer among the Egyptian population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gene Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jgm.3381"}], "href": "https://doi.org/10.1002/jgm.3381"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34312940"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34312940"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Jiawu Wang, Chengyao Zhang, Yan Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell Int (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12935-019-1052-2"}], "href": "https://doi.org/10.1186/s12935-019-1052-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31827401"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31827401"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Wen Xu, Bei Wang, Yuxuan Cai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ADAMTS9-AS2: A Functional Long Non-coding RNA in Tumorigenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Pharm Des (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/1381612827666210325105106"}], "href": "https://doi.org/10.2174/1381612827666210325105106"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33823762"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33823762"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Zhichao Lin, Wenhai Huang, Yongsheng Yi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA ADAMTS9-AS2 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Gen Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2147/IJGM.S340683"}], "href": "https://doi.org/10.2147/IJGM.S340683"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34849000"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34849000"}]}]}]}
|
| NCBI Gene ID | 100507098 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
ADAMTS9-AS2 has 1,398 functional associations with biological entities spanning 6 categories (molecular profile, organism, disease, phenotype or trait, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 24 datasets.
Click the + buttons to view associations for ADAMTS9-AS2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of ADAMTS9-AS2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of ADAMTS9-AS2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of ADAMTS9-AS2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of ADAMTS9-AS2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at ADAMTS9-AS2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of ADAMTS9-AS2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of ADAMTS9-AS2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of ADAMTS9-AS2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of ADAMTS9-AS2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of ADAMTS9-AS2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of ADAMTS9-AS2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of ADAMTS9-AS2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of ADAMTS9-AS2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of ADAMTS9-AS2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of ADAMTS9-AS2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with ADAMTS9-AS2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with ADAMTS9-AS2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with ADAMTS9-AS2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with ADAMTS9-AS2 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with ADAMTS9-AS2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of ADAMTS9-AS2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of ADAMTS9-AS2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of ADAMTS9-AS2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at ADAMTS9-AS2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |